Chronic prostatitis
Conditions
Interventions
control group:Qianlietai granule
experimental group:Danyi Tablet
Sponsors
Second affiliated Hospital of Tianjin University of TCM
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. meet the diagnostic criteria of Chronic Prostatitis; 2. meet the diagnostic criteria of pattern of static blood obstructing and dampness-heat pouring down; 3. age 18-50 years old, male; 4. The course of the disease>=3 months; 5. not receive the similar drug therapy or other treatment in the last two weeks; 6. Signed the informed consent form prior to the study participation.
Exclusion criteria
Exclusion criteria: 1. benign prostatic hyperplasia, prostate cancer, neurogenic bladder, urethritis, urethral malformation or stenosis and severe neurosis; 2. to local pain as the main manifestations of the patients, attention should be paid to exclude the lower abdomen, perineum, lumbosacral and other parts of the other lesions, such as ureteral calculus, vesical calculus, inguinal hernia, osteitis pubis, varicocele, epididymitis, rectosigmoid colon diseases, such as lumbar back myofascitis; 3. combine heart, brain, liver and kidney and hematopoietic system of severe primary diseases; 4. allergic or to test drug ingredients known allergy; 5. active ulceration and bleeding tendency; 6. cannot be partners, such as psychiatric patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI score (total score, pain score, QOL score); | — |
Secondary
| Measure | Time frame |
|---|---|
| the general therapeutic effect of Chinese medicine;Chinese medicine syndrome score;the single-item score of Chinese medicine syndrom;EPS examination;prostate digital examination; | — |
Countries
China
Contacts
Public ContactWei Rui
Outcome results
None listed